dual glp-1/glucagon receptor agonists The agonist action of tirzepatide on various organs. GLP-1: Dual and Triple Gut Peptide
Description
And for those exploring GLP-1s for weight loss, it's a much more sustainable way to manage weight (low and slow is the way to go)

With incretin-based drugs, much of the reported lean mass loss may not be skeletal muscle, but some is

Introduction Our study has two objectives: (1) to evaluate the incidence and severity of food retention observed during esophagogastroduodenoscopies (EGDs) in patients with and without history of glucagon-like peptide-1 receptor agonist (GLP-1 RA) use and (2) to create a grading scale to standardize the language regarding food retention

While most health plans do not currently cover obesity medications like Wegovy and Zepbound and MedBen Rx recommends clients continue not to do so constant media coverage means the calls to do so will only grow

Advanced Metabolic Signaling Research
